[HTML][HTML] Integration strategies of multi-omics data for machine learning analysis

M Picard, MP Scott-Boyer, A Bodein, O Périn… - Computational and …, 2021 - Elsevier
Increased availability of high-throughput technologies has generated an ever-growing
number of omics data that seek to portray many different but complementary biological …

Applications of multi‐omics analysis in human diseases

C Chen, J Wang, D Pan, X Wang, Y Xu, J Yan… - MedComm, 2023 - Wiley Online Library
Multi‐omics usually refers to the crossover application of multiple high‐throughput screening
technologies represented by genomics, transcriptomics, single‐cell transcriptomics …

Artificial intelligence in early drug discovery enabling precision medicine

F Boniolo, E Dorigatti, AJ Ohnmacht… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction: Precision medicine is the concept of treating diseases based on environmental
factors, lifestyles, and molecular profiles of patients. This approach has been found to …

[HTML][HTML] Advances in proteomic and metabolomic profiling of neurodegenerative diseases

A Schumacher-Schuh, A Bieger, WV Borelli… - Frontiers in …, 2022 - frontiersin.org
Proteomics and metabolomics are two emerging fields that hold promise to shine light on the
molecular mechanisms causing neurodegenerative diseases. Research in this area may …

[HTML][HTML] Towards building a quantitative proteomics toolbox in precision medicine: a mini-review

A Correa Rojo, D Heylen, J Aerts, O Thas… - Frontiers in …, 2021 - frontiersin.org
Precision medicine as a framework for disease diagnosis, treatment, and prevention at the
molecular level has entered clinical practice. From the start, genetics has been an …

[HTML][HTML] Functional genomics in stroke: current and future applications of iPSCs and gene editing to dissect the function of risk variants

A Granata - BMC cardiovascular disorders, 2023 - Springer
Stroke is an important disease with unmet clinical need. To uncover novel paths for
treatment, it is of critical importance to develop relevant laboratory models that may help to …

Intersection of network medicine and machine learning towards investigating the key biomarkers and pathways underlying amyotrophic lateral sclerosis: a systematic …

T Das, H Kaur, P Gour, K Prasad… - Briefings in …, 2022 - academic.oup.com
Background Network medicine is an emerging area of research that focuses on delving into
the molecular complexity of the disease, leading to the discovery of network biomarkers and …

Integrated multi-omic data analysis and validation with yeast model show oxidative phosphorylation modulates protein aggregation in amyotrophic lateral sclerosis

R Sai Swaroop, PS Akhil, P Sai Sanwid… - Journal of …, 2023 - Taylor & Francis
Abstract Amyotrophic Lateral Sclerosis is a progressive, incurable amyloid aggregating
neurodegenerative disease involving the motor neurons. Identifying potential biomarkers …

Integrated network pharmacology approach shows a potential role of Ginseng catechins and ginsenosides in modulating protein aggregation in Amyotrophic Lateral …

RS Swaroop, SS Pradhan, VMD Darshan… - 3 Biotech, 2022 - Springer
Amyotrophic lateral Sclerosis is an incurable, progressive neurodegenerative motor neuron
disease. The disease is characterized by protein aggregates. The symptoms include …

Mutant VAPB: culprit or innocent bystander of amyotrophic lateral sclerosis?

N Borgese, F Navone, N Nukina, T Yamanaka - Contact, 2021 - journals.sagepub.com
Nearly twenty years ago a mutation in the VAPB gene, resulting in a proline to serine
substitution (p. P56S), was identified as the cause of a rare, slowly progressing, familial form …